Icon Cancer Centre

South Brisbane QLD 4101

1 studies enrolling now · 3 studies all time

What they study most

Fallopian Tube Cancer, G12D Mutated KRAS, Metastatic Urothelial Cancer, Pancreatic Ductal Adenocarcinoma (PDAC), Platinum-resistant Ovarian Cancer, Primary Peritoneal Cancer

Studies at this site

• A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer — Recruiting now
• Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) — Running, not enrolling
• Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) — Stopped early